Evaluation of Potential Antihypertensive Drug Interactions in Hospitalized Patients: A Retrospective Study Based on Medical Records

Main Article Content

Annora rizky amalia
Alfina Nurrahman
Bella Anggreyani Yusuf

Abstract

Hypertension is a chronic disease that requires long-term treatment. The concomitant use of multiple medications in hospitalized patients may increase the risk of potential drug interactions, which can affect treatment effectiveness and patient safety. This study aimed to evaluate potential antihypertensive drug interactions in hospitalized patients based on medical record data. A descriptive study with a retrospective design was conducted by reviewing the medical records of patients with hypertension at a regional public hospital in Central Java. The samples were selected using purposive sampling according to the predetermined inclusion and exclusion criteria. Potential drug interactions were analyzed based on the combinations of medications prescribed during hospitalization. The results showed that 85 patients (70.83%) had potential drug interactions, with a total of 208 interaction events, of which 155 (74.52%) involved antihypertensive drugs. The most frequent potential interaction occurred between amlodipine and Santagesik, accounting for 20 events (9.62%). Most interactions were classified as significant (77.40%) and were predominantly pharmacokinetic in mechanism (79.81%). Potential antihypertensive drug interactions remain common among hospitalized patients, highlighting the importance of regular therapy evaluation and medication monitoring to improve treatment safety and effectiveness.

Downloads

Download data is not yet available.

Article Details

How to Cite
amalia, A. rizky, Nurrahman, A., & Yusuf, B. A. (2026). Evaluation of Potential Antihypertensive Drug Interactions in Hospitalized Patients: A Retrospective Study Based on Medical Records. Jurnal Surya Medika (JSM), 12(1). Retrieved from https://journal.umpr.ac.id/index.php/jsm/article/view/13410
Section
Articles

References

Eka Putri Nurhidayah, Faizal Agustino, B. F. A. (2025). Hipertensi Dengan Komorbiditas Di Rumah Sakit X Evaluation Of Drug Interaction Risk And Patterns In Hypertensive Patients With Comorbidities At X Hospital. Social Clinical Pharmacy Indonesia Journal, 49–57.

Faisal, S., Khotib, J., Wibisono, C., Hamidah, K. F., Utomo, F. N., & Zairina, E. (2025). Factors Contributing To The Prevalence Of Potential Drug-Drug Interactions Among Hospitalized Elderly Patients In A Tertiary Hospital In Eastern Java , Indonesia. Medical Journal Of Indonesia, 34(3), 174–180.

Febriyenti, A., Yosmar, R., & Permatasari, D. (2025). Original Article Cardiovascular Drug – Drug Interactions ( Ddis ) In Coronary Heart Disease Patients With Hypertension Analisis Interaksi Obat-Obat Kardiovaskular Pada Pasien Jantung Koroner Dengan Riwayat Hipertensi Abstrak. Journal Of Pharmaceutical And Sciences, 2711–2720.

Hidayati, N. R., Sulastri, L., Indriaty, S., Karlina, N., Zahra, N. B., Tinggi, S., & Muhammadiyah, F. (2024). Di Instalasi Rawat Inap Rsd Gunung Jati Cirebon Penelitian Dilaksanakan Di Ruang Instalasi Rekam Medik Dan Instalasi Rawat Inap Rsd. Journal Of Pharmacopolium, 7(1), 16–28.

Khan, M. A., Syafhan, N. F., Andrajati, R., Wispriyono, B., & Noor, S. (2024). Prevalence And Associated Factors Of Drug-Drug Interactions In Hospitalized Diabetic Patients : A Cross-Sectional Study. Jurnal Sains Farmasi & Klinis, 86–94. Https://Doi.Org/10.25077/Jsfk.11.2.86-94.2024

Pambudi, R. (2024). Indonesian Journal Of Pharmacy And Natural Product. Indonesian Journal Of Pharmacy And Natural Product, 07, 41–46.

Perhi. (2024). Panduan Pengenalan Dan Tatalaksana Hipertensi Resisten Di Indonesia.

Permatasari, J., Mitra, A. D., & Ilmi, M. (2024). Polifarmasi Pasien Hipertensi Rawat Jalan Di Rumah Sakit X Di Kabupaten Batang Hari Periode Januari - Maret Tahun 2023. Jurnal Kesehatan Tambusai, 5, 23–28.

Pnpk. (2021). Tata Laksana Hipertensi Dewasa.

Razoki; Harahap, Rezki Sari; Sembiring, Novitaria Br; Neswita, E. (2023). Clinical Screening Of Polypharmacy Prescriptions In Hypertensive Patients At Advent Hospital. Journal Of Pharmaceutical And Sciences, 6(2), 707–712.

Saraswati, M. D., Ardiana, S. M., Suprapti, B., Assegaf, M. Y., & Fitri, K. (2022). Potential Drug – Drug Interactions Hypertension : A Retrospective Study In Ambulatory Patients With. Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia, 9(1), 69–74. Https://Doi.Org/10.20473/Jfiki.V9i12022.69-74

Schmitt, J. P., Kirfel, A., Schmitz, M., Kohlhof, H., Weisbarth, T., & Wittmann, M. (2022). The Impact Of Drug Interactions In Patients With Community-Acquired Pneumonia On Hospital Length Of Stay. Geriatrics, 3–11.

Siregar, S. R., Fitriany, J., Utariningsih, W., Husni, M., Nasution, F., Balqis, K. M., Tingkat, A., Sarah, P., Siregar, R., Fitriany, J., Volume, G., Bulan, N., & Hal, T. (2025). Analisis Tingkat Polifarmasi Dan Kepatuhan Pengobatan Terhadap Risiko Drug Related Problems Pada Pasien Prolanis Di Puskesmas Dewantara Aceh Utara Galenical Is Licensed Under A Creative Commons Attribution-Sharealike. Galenical: Jurnal Kedokteran Dan Kesehatan Mahasiswa Malikussaleh, 4(6), 13–23.

Tanty, H. (2025). Polifarmasi Dan Potensi Interaksi Obat: Studi Pada Pasien Geriatri Hipertensi Rawat Inap Di Rs Islam Jakarta Pondok Kopi (Maret 2024 - Februari 2025). Jurnal Farmasi Ikifa, 4(3), 103–115.

Titami, A., Wiedyaningsih, C., & Pramantara, I. D. P. (2025). Drug-Drug Interactions ( Ddis ) In Elderly Hypertensive Inpatients Of The Academic Hospital Of Universitas Gadjah Mada Yogyakarta. Jurnal Manajemen Dan Pelayanan Farmasi (Jmpf), 15(1), 73–78. Https://Doi.Org/10.22146/Jmpf.101799

Wahidah, P. K., Wulan, D., Rengganis, S., Iyos, R. N., Studi, P., Dokter, P., Kedokteran, F., Lampung, U., Masyarakat, B. K., Kedokteran, F., Lampung, U., Kardiovaskuler, B., Kedokteran, F., & Lampung, U. (2024). Penggunaan Oains Sebagai Faktor Risiko Dispepsia : Tinjauan Literatur Nsaid Use As A Risk Factor For Dyspepsia : Literature Review. Medula, 14, 1959–1962.

Waningsih, A. (2025). Hubungan Potensi Interaksi Obat Antihipertensi. Journal Of Pharaceutical, 3(2), 36–46.